Cardiovascular
Researchers' work from University of Chicago focuses on cardiovascular
Published in Cardiovascular Business Week, February 23rd, 2010
Data detailed in 'Are there effects of renin-angiotensin system antagonists beyond blood pressure control' have been presented. According to recent research from the United States, "Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) are recognized to reduce cardiovascular and renal morbidity and mortality, which is primarily attributed to their antihypertensive effects. Activation of the renin-angiotensin system (RAS) may also play an important role in the pathogenesis of cardiovascular and renal disease through blood pressure-independent mechanisms mediated by angiotensin II."
"Thus, inhibiting the RAS with either an ARB or an ACE...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- 3SBio Inc.
3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil for Hyperphosphatemia - AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals Provides Feraheme(R) Safety Update - American Egg Board
Cracking Cholesterol Confusion During American Heart Month - American Heart Association
Age-Related Gaps Closing, Patient Care and Outcomes Improving at Get With the Guidelines-Stroke Hospitals - American Heart Association
American Heart Association Comment on Hospitalization of President Bill Clinton - American Heart Association
American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
